Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen F Madden

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
BMC Bioinformatics|May 21, 2010
Detecting microRNA activity from gene expression dataStephen F Madden, Susan B Carpenter, Ian B Jeffery, et al.
Endocrine-Related Cancer|March 3, 2016
Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cellsFrancesco Caiazza, Alyson Murray, Stephen F Madden, et al.
Endocrine-Related Cancer|February 19, 2017
Vitamin D receptor as a target for breast cancer therapyAlyson Murray, Stephen F Madden, Naoise C Synnott, et al.
Clinical Epigenetics|February 13, 2021
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cellsGordon Greville, Esther Llop, Jane Howard, et al.
International Journal of Oncology|May 13, 2017
Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cellsMartina S J McDermott, Alexandra Canonici, Laura Ivers, et al.
Cellular Immunology|July 25, 2017
Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell linesDenis M Collins, Kathy Gately, Clare Hughes, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Molecular Cancer Therapeutics|July 11, 2019
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to TherapyLaura Creevey, Rachel Bleach, Stephen F Madden, et al.
Molecular Cancer|October 26, 2014
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasetsStephen F Madden, Colin Clarke, Britta Stordal, et al.
BMC Cancer|May 1, 2015
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progressionSinéad T Aherne, Stephen F Madden, David J Hughes, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
BMC Bioinformatics|May 21, 2010
Detecting microRNA activity from gene expression dataStephen F Madden, Susan B Carpenter, Ian B Jeffery, et al.
Endocrine-Related Cancer|March 3, 2016
Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cellsFrancesco Caiazza, Alyson Murray, Stephen F Madden, et al.
Endocrine-Related Cancer|February 19, 2017
Vitamin D receptor as a target for breast cancer therapyAlyson Murray, Stephen F Madden, Naoise C Synnott, et al.
Clinical Epigenetics|February 13, 2021
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cellsGordon Greville, Esther Llop, Jane Howard, et al.
International Journal of Oncology|May 13, 2017
Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cellsMartina S J McDermott, Alexandra Canonici, Laura Ivers, et al.
Cellular Immunology|July 25, 2017
Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell linesDenis M Collins, Kathy Gately, Clare Hughes, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Molecular Cancer Therapeutics|July 11, 2019
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to TherapyLaura Creevey, Rachel Bleach, Stephen F Madden, et al.
Molecular Cancer|October 26, 2014
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasetsStephen F Madden, Colin Clarke, Britta Stordal, et al.
BMC Cancer|May 1, 2015
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progressionSinéad T Aherne, Stephen F Madden, David J Hughes, et al.
Pageof 8